CL/F was estimated to be 30% lower in the presence of strong CYP3A4 inhibitors and 2.24-fold higher in the presence of strong CYP3A4 inducers, and to be 24% lower for transplant recipients with CMV infection than for all other individuals. This evidence concerns the gene CYP3A4 and cytomegalovirus infection.